MarketLens
Sign Up

Why is Amanah Holdings Trust Making Such Concentrated Bets in Pharma and Semiconductors

5 months ago
SHARE THIS ON:

Why is Amanah Holdings Trust Making Such Concentrated Bets in Pharma and Semiconductors

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News3 weeks ago

EMEQ: A Concentrated Bet On Emerging Market Champions

EMEQ returned 81.80% NAV since September 2024, outperforming its benchmark, driven by concentrated bets on emerging market semiconductor and AI leaders. Its top 10 holdings comprise ~68% of assets, am...
News2 months ago

Trump's Trust Made a Hard Pivot from Bonds to Stocks This Year—What the Thousands of Trades Reveal

President Trump’s trust executed over 5,200 securities trades during his second term, with ~75% occurring in Q1 2025. The portfolio shifted its strategy from a fixed-income focus to active stock tradi...
Stock News2 months ago

The Stocks Behind the Stocks Every AI Investor Is Missing

Investor Alex Sacerdote employs a contrarian strategy by positioning portfolios ahead of emerging market trends. This approach prioritizes long-term anticipation of sector shifts rather than chasing i...
Stock News2 months ago

Why the Healthcare Sector Warrants Concentrated Exposure

The healthcare sector may warrant concentrated equity exposure despite the general benefits of portfolio diversification. This outlook suggests that specific sector fundamentals currently offer more p...

Breaking News

View All →

Top Headlines

View More →
Stock News44 minutes ago

Alphabet Is Worth $4.6 Trillion. Here's What Has to Happen for the Stock to Double by 2032.

Stock News55 minutes ago

Advanced Micro Devices Q2 Earnings Call Highlights

Stock News59 minutes ago

Early August Rally Brings Record Closing Highs

Stock News1 hour ago

3 Reasons to Buy Apple Stock on the Dip as CEO Tim Cook Steps Down

Stock News1 hour ago

Advanced Micro Devices (AMD) Surpasses Q2 Earnings and Revenue Estimates